BMRN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 1.85%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $17,505,828.26

BioMarin Pharmaceutical Insider Trading History Chart

BioMarin Pharmaceutical Share Price & Price History

^$71.41

▲ +0.27 (0.38%)

As of 09/19/2024 06:11 PM ET

Days: 30 | 90 | 365

Trump’s weapon lurks in abandoned America

From Porter & Company | Ad

Unemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. Hopelessness abounds. And looking in, the future here looks bleak for these forgotten souls. But in a strange twist of fate, something miraculous is taking place…

Go here now to watch my new documentary

BioMarin Pharmaceutical Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/30/2024	Brian R. Mueller	CFO	Sell	5,000	$75.19	$375,950.00	72,159
5/28/2024	George Eric Davis	EVP	Sell	40,850	$74.51	$3,043,733.50	56,157
5/9/2024	Jean Jacques Bienaime	Director	Sell	20,000	$81.62	$1,632,400.00	474,994
5/2/2024	George Eric Davis	EVP	Sell	1,850	$85.01	$157,268.50	56,157
4/12/2024	Jean Jacques Bienaime	Director	Sell	20,000	$91.26	$1,825,200.00	474,994
4/10/2024	Erin Burkhart	CAO	Sell	2,286	$90.00	$205,740.00	16,156
3/28/2024	George Eric Davis	EVP	Sell	24,602	$88.34	$2,173,340.68	55,856
3/5/2024	Henry J. Fuchs	Insider	Sell	35,341	$85.18	$3,010,346.38	212,117
3/5/2024	Jean Jacques Bienaime	Director	Sell	1,000	$85.51	$85,510.00	561,203
3/5/2024	Jeffrey Robert Ajer	EVP	Sell	4,000	$87.07	$348,280.00	94,047
2/27/2024	Jean Jacques Bienaime	Director	Sell	1,000	$90.35	$90,350.00	562,203
2/9/2024	Jean Jacques Bienaime	Director	Sell	15,000	$88.28	$1,324,200.00	419,602
1/9/2024	Jean Jacques Bienaime	Director	Sell	10,000	$98.19	$981,900.00	425,162
12/21/2023	Jean Jacques Bienaime	Director	Sell	10,000	$93.99	$939,900.00	425,112
12/13/2023	George Eric Davis	EVP	Sell	13,764	$95.30	$1,311,709.20	55,710
8/16/2023	Jeffrey Robert Ajer	EVP	Sell	5,000	$90.00	$450,000.00	60,804
8/10/2023	Henry J. Fuchs	Insider	Sell	12,000	$90.43	$1,085,160.00	176,187
8/8/2023	George Eric Davis	EVP	Sell	11,000	$89.42	$983,620.00	69,474
8/7/2023	Jean Jacques Bienaime	CEO	Sell	4,000	$88.10	$352,400.00	428,732
5/10/2023	Jean Jacques Bienaime	CEO	Sell	30,000	$94.85	$2,845,500.00	426,213
4/10/2023	Jean Jacques Bienaime	CEO	Sell	10,000	$99.56	$995,600.00	425,896
4/6/2023	Jean Jacques Bienaime	CEO	Sell	10,000	$96.13	$961,300.00	425,896
4/3/2023	V. Bryan Lawlis	Director	Sell	8,500	$97.09	$825,265.00	28,950
3/13/2023	Jean Jacques Bienaime	CEO	Sell	8,000	$90.45	$723,600.00	487,856
3/10/2023	Jean Jacques Bienaime	CEO	Sell	15,000	$92.28	$1,384,200.00	487,856
2/13/2023	Jean Jacques Bienaime	CEO	Sell	6,000	$109.15	$654,900.00	320,324
2/10/2023	Jean Jacques Bienaime	CEO	Sell	15,000	$110.11	$1,651,650.00	320,324
1/25/2023	Jeffrey Robert Ajer	EVP	Sell	49,000	$115.70	$5,669,300.00	41,088
1/17/2023	Jean Jacques Bienaime	CEO	Sell	10,000	$111.55	$1,115,500.00	320,424
1/13/2023	Brian R. Mueller	CFO	Sell	2,500	$114.50	$286,250.00	27,746
1/13/2023	Jean Jacques Bienaime	CEO	Sell	10,000	$112.25	$1,122,500.00	320,424
12/13/2022	Brian R. Mueller	CFO	Sell	2,500	$107.50	$268,750.00	27,746
12/13/2022	Jean Jacques Bienaime	CEO	Sell	1,000	$106.89	$106,890.00	320,424
12/2/2022	Brian R. Mueller	CFO	Sell	7,001	$104.50	$731,604.50	27,746
12/2/2022	Jean Jacques Bienaime	CEO	Sell	1,500	$103.98	$155,970.00	321,424
11/23/2022	Brian R. Mueller	CFO	Sell	5,379	$98.73	$531,068.67	28,847
11/2/2022	Jeffrey Robert Ajer	EVP	Sell	3,000	$86.12	$258,360.00	41,088
10/31/2022	Jean Jacques Bienaime	CEO	Sell	1,500	$86.55	$129,825.00	322,824
10/31/2022	Mark J. Alles	Director	Buy	3,625	$86.75	$314,468.75	10,905
10/14/2022	Jean Jacques Bienaime	CEO	Sell	4,000	$89.89	$359,560.00	324,324
8/15/2022	Jean Jacques Bienaime	CEO	Sell	3,000	$95.21	$285,630.00	328,324
8/12/2022	Jean Jacques Bienaime	CEO	Sell	4,000	$94.75	$379,000.00	331,324
8/11/2022	Jeffrey Robert Ajer	EVP	Sell	3,000	$95.62	$286,860.00	44,088
8/8/2022	Charles Greg Guyer	EVP	Sell	6,205	$96.56	$599,154.80	42,168
7/8/2022	Brian R. Mueller	CFO	Sell	7,337	$89.50	$656,661.50	30,726
7/8/2022	George Eric Davis	EVP	Sell	7,398	$90.00	$665,820.00	58,941
5/26/2022	Jeffrey Robert Ajer	EVP	Sell	1,308	$78.94	$103,253.52	54,109
5/5/2022	Jean Jacques Bienaime	CEO	Sell	10,000	$84.14	$841,400.00	335,324
5/4/2022	Brian R. Mueller	CFO	Sell	11,800	$84.50	$997,100.00	38,639
5/2/2022	George Eric Davis	EVP	Sell	15,347	$80.38	$1,233,591.86	66,339
5/2/2022	Richard A. Meier	Director	Sell	3,878	$82.09	$318,345.02	104,014
4/28/2022	Jean Jacques Bienaime	CEO	Sell	20,000	$83.79	$1,675,800.00	334,983
4/18/2022	Jean Jacques Bienaime	CEO	Sell	20,000	$81.91	$1,638,200.00	334,983
4/14/2022	Jean Jacques Bienaime	CEO	Sell	10,000	$83.66	$836,600.00	334,983
4/14/2022	V. Bryan Lawlis	Director	Sell	4,250	$83.66	$355,555.00	23,970
4/13/2022	Jeffrey Robert Ajer	EVP	Sell	1,180	$82.47	$97,314.60	55,077
3/29/2022	Jeffrey Robert Ajer	EVP	Sell	1,618	$79.43	$128,517.74
3/23/2022	Jeffrey Robert Ajer	EVP	Sell	6,129	$81.78	$501,229.62
3/21/2022	George Eric Davis	EVP	Sell	6,129	$81.29	$498,226.41
3/10/2022	Jean Jacques Bienaime	CEO	Sell	15,000	$77.57	$1,163,550.00
2/28/2022	Dennis Slamon	Director	Sell	6,396	$78.33	$500,998.68
1/14/2022	V. Bryan Lawlis	Director	Sell	4,250	$87.61	$372,342.50
1/13/2022	Jean Jacques Bienaime	CEO	Sell	5,000	$87.86	$439,300.00
12/15/2021	Jean Jacques Bienaime	CEO	Sell	6,000	$82.71	$496,260.00
12/1/2021	Jean Jacques Bienaime	CEO	Sell	1,500	$87.22	$130,830.00
10/26/2021	Jeffrey Robert Ajer	EVP	Sell	2,739	$73.60	$201,590.40

Have you heard of this 5-Day Challenge yet?

From InvestorPlace | Ad

You'll be interested in our 5-Day Options Trading Challenge, starting September 23. So, what makes this different from every other options research you may have seen? Well, for starters... most of them want you to first BUY their service... which is usually thousands of dollars...

Just click here to get the full details on the 5-Day Options Trading Challenge, before this offer go

SEC Filings (Institutional Ownership Changes) for BioMarin Pharmaceutical (NASDAQ:BMRN)

98.71% of BioMarin Pharmaceutical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

BioMarin Pharmaceutical Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/17/2024	University of Texas Texas AM Investment Management Co.	9,133	$0.75M	0.1%	-37.9%	0.005%
9/5/2024	Sanctuary Advisors LLC	22,043	$1.78M	0.0%	N/A	0.012%
8/27/2024	Clearbridge Investments LLC	259,573	$21.37M	0.0%	-0.6%	0.137%
8/26/2024	Teachers Retirement System of The State of Kentucky	194,207	$15.99M	0.1%	+17.4%	0.102%
8/20/2024	Novo Holdings A S	490,000	$40.34M	2.0%	+8.9%	0.258%
8/16/2024	NewEdge Advisors LLC	10,885	$0.90M	0.0%	+3,931.5%	0.006%
8/16/2024	Creative Planning	11,825	$0.97M	0.0%	+4.6%	0.006%
8/15/2024	Susquehanna Fundamental Investments LLC	68,346	$5.63M	0.1%	N/A	0.036%
8/15/2024	Lighthouse Investment Partners LLC	63,000	$5.19M	0.2%	N/A	0.033%
8/15/2024	Mackenzie Financial Corp	30,474	$2.51M	0.0%	+18.8%	0.016%
8/15/2024	The Manufacturers Life Insurance Company	180,617	$14.87M	0.0%	+177.7%	0.095%
8/15/2024	MBB Public Markets I LLC	11,991	$0.99M	0.0%	N/A	0.006%
8/15/2024	D. E. Shaw & Co. Inc.	268,374	$22.10M	0.0%	-36.4%	0.141%
8/15/2024	Deerfield Management Company L.P. Series C	9,832	$0.81M	0.0%	N/A	0.005%
8/15/2024	DeepCurrents Investment Group LLC	117,182	$9.65M	0.4%	-13.3%	0.062%
8/15/2024	Employees Retirement System of Texas	491,100	$40.43M	0.4%	+42.8%	0.259%
8/15/2024	APG Asset Management N.V.	334,891	$25.73M	0.0%	-16.4%	0.176%
8/15/2024	APG Asset Management US Inc.	53,808	$4.42M	0.0%	+2.5%	0.028%
8/15/2024	AQR Capital Management LLC	55,372	$4.56M	0.0%	+144.3%	0.029%
8/15/2024	AXA S.A.	573,071	$47.18M	0.1%	-51.2%	0.302%
8/15/2024	Troluce Capital Advisors LLC	71,600	$5.90M	0.6%	N/A	0.038%
8/15/2024	Toronto Dominion Bank	18,231	$1.50M	0.0%	-7.7%	0.010%
8/14/2024	Fred Alger Management LLC	29,516	$2.43M	0.0%	-5.3%	0.016%
8/14/2024	BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	36,343	$2.99M	0.0%	+61.6%	0.019%
8/14/2024	Marshall Wace LLP	42,738	$3.52M	0.0%	-45.9%	0.023%
8/14/2024	Xponance Inc.	29,307	$2.41M	0.0%	+66.5%	0.015%
8/14/2024	Magnetar Financial LLC	8,816	$0.73M	0.0%	N/A	0.005%
8/14/2024	Avoro Capital Advisors LLC	4,557,416	$375.21M	5.0%	+4.4%	2.400%
8/14/2024	Gabelli Funds LLC	8,039	$0.66M	0.0%	+16.1%	0.004%
8/14/2024	Itau Unibanco Holding S.A.	569	$47K	0.0%	N/A	0.000%
8/14/2024	1832 Asset Management L.P.	23,191	$1.91M	0.0%	+17.6%	0.012%
8/14/2024	ProShare Advisors LLC	20,677	$1.70M	0.0%	+56.4%	0.011%
8/14/2024	Profund Advisors LLC	44,663	$3.68M	0.1%	+176.4%	0.024%
8/13/2024	Ensign Peak Advisors Inc	71,888	$5.92M	0.0%	-0.4%	0.038%
8/13/2024	Ameritas Investment Partners Inc.	40,387	$3.33M	0.2%	N/A	0.021%
8/13/2024	Pacer Advisors Inc.	37,332	$3.07M	0.0%	+7,321.9%	0.020%
8/13/2024	Simplify Asset Management Inc.	5,067	$0.42M	0.0%	N/A	0.003%
8/13/2024	Canada Pension Plan Investment Board	240,516	$19.80M	0.0%	-23.1%	0.127%
8/13/2024	Public Employees Retirement Association of Colorado	19,801	$1.63M	0.0%	-6.1%	0.010%
8/12/2024	Intech Investment Management LLC	58,023	$4.78M	0.1%	+59.6%	0.031%
8/12/2024	MQS Management LLC	6,818	$0.56M	0.3%	N/A	0.004%
8/12/2024	XTX Topco Ltd	5,018	$0.41M	0.0%	-55.0%	0.003%
8/12/2024	Hsbc Holdings PLC	89,795	$7.41M	0.0%	-61.4%	0.047%
8/12/2024	Elo Mutual Pension Insurance Co	16,883	$1.39M	0.0%	-1.4%	0.009%
8/12/2024	Blair William & Co. IL	36,834	$3.03M	0.0%	-2.5%	0.019%
8/12/2024	Vanguard Personalized Indexing Management LLC	10,631	$0.88M	0.0%	+14.6%	0.006%
8/12/2024	Amalgamated Bank	95,922	$7.90M	0.1%	+792.7%	0.051%
8/12/2024	Tredje AP fonden	29,330	$2.42M	0.0%	-1.6%	0.015%
8/12/2024	Meiji Yasuda Asset Management Co Ltd.	12,637	$1.04M	0.0%	+83.0%	0.007%
8/12/2024	Meiji Yasuda Life Insurance Co	10,942	$0.90M	0.0%	+57.6%	0.006%
8/12/2024	E Fund Management Co. Ltd.	13,480	$1.11M	0.1%	+167.4%	0.007%
8/10/2024	Mutual of America Capital Management LLC	108,713	$8.95M	0.1%	N/A	0.057%
8/9/2024	Primecap Management Co. CA	18,790,085	$1.55B	1.1%	+0.4%	9.896%
8/9/2024	Renaissance Technologies LLC	116,200	$9.57M	0.0%	-78.6%	0.061%
8/9/2024	Dimensional Fund Advisors LP	1,034,457	$85.18M	0.0%	+38.9%	0.545%
8/9/2024	Plato Investment Management Ltd	5,068	$0.42M	0.0%	N/A	0.003%
8/9/2024	WINTON GROUP Ltd	6,188	$0.51M	0.0%	N/A	0.003%
8/8/2024	LWM Advisory Services LLC	3,516	$0.29M	0.2%	N/A	0.002%
8/8/2024	Federated Hermes Inc.	20,167	$1.66M	0.0%	N/A	0.011%
8/8/2024	DekaBank Deutsche Girozentrale	281,091	$23.49M	0.0%	+0.3%	0.148%
8/8/2024	BOKF NA	375	$31K	0.0%	N/A	0.000%
8/8/2024	Thornburg Investment Management Inc.	161,446	$13.29M	0.2%	-2.1%	0.085%
8/8/2024	Forsta AP Fonden	33,000	$2.72M	0.0%	-9.1%	0.017%
8/8/2024	State of New Jersey Common Pension Fund D	68,403	$5.63M	0.0%	-35.5%	0.036%
8/8/2024	Rice Hall James & Associates LLC	20,679	$1.70M	0.1%	-28.0%	0.011%
8/7/2024	AGF Management Ltd.	31,130	$2.56M	0.0%	N/A	0.016%
8/7/2024	Daiwa Securities Group Inc.	16,821	$1.39M	0.0%	+3.2%	0.009%
8/7/2024	Andra AP fonden	18,400	$1.52M	0.0%	N/A	0.010%
8/7/2024	Royal London Asset Management Ltd.	73,287	$6.03M	0.0%	+1.5%	0.039%
8/7/2024	Texas Permanent School Fund Corp	26,646	$2.19M	0.0%	N/A	0.014%
8/7/2024	Freemont Management S.A.	8,600	$0.71M	0.3%	-83.1%	0.005%
8/7/2024	United Services Automobile Association	14,811	$1.22M	0.0%	N/A	0.008%
8/6/2024	Acadian Asset Management LLC	12,113	$0.99M	0.0%	+377.5%	0.006%
8/6/2024	New Mexico Educational Retirement Board	38,500	$3.17M	0.1%	N/A	0.020%
8/6/2024	Torray Investment Partners LLC	16,855	$1.39M	0.2%	+13.6%	0.009%
8/6/2024	EFG Asset Management Americas Corp.	30,807	$2.54M	0.5%	+55.5%	0.016%
8/6/2024	Candriam S.C.A.	525,138	$43.23M	0.3%	+38.7%	0.277%
8/5/2024	Arizona State Retirement System	52,130	$4.29M	0.0%	+0.6%	0.027%
8/3/2024	National Bank of Canada FI	14,383	$1.18M	0.0%	-93.6%	0.008%
8/3/2024	TD Asset Management Inc	143,897	$11.85M	0.0%	-9.3%	0.076%
8/2/2024	Mesirow Institutional Investment Management Inc.	40,788	$3.36M	0.3%	+28.4%	0.021%
8/2/2024	Oregon Public Employees Retirement Fund	39,400	$3.24M	0.1%	N/A	0.021%
8/2/2024	Comgest Global Investors S.A.S.	152,777	$12.58M	0.2%	-28.1%	0.080%
8/1/2024	Fiera Capital Corp	622,953	$51.29M	0.2%	+1.1%	0.328%
8/1/2024	Rhumbline Advisers	551,553	$45.41M	0.0%	+122.1%	0.290%
8/1/2024	CIBC Asset Management Inc	6,372	$0.53M	0.0%	+5.4%	0.003%
8/1/2024	Natixis Advisors LLC	18,901	$1.56M	0.0%	-65.9%	0.010%
8/1/2024	GraniteShares Advisors LLC	7,107	$0.59M	0.2%	N/A	0.004%
8/1/2024	AM Squared Ltd	800	$66K	0.2%	N/A	0.000%
7/31/2024	Van ECK Associates Corp	133,522	$10.99M	0.0%	-6.5%	0.070%
7/31/2024	Private Ocean LLC	1,450	$0.12M	0.0%	N/A	0.001%
7/30/2024	Fort Washington Investment Advisors Inc. OH	978,638	$80.57M	0.5%	-16.2%	0.515%
7/30/2024	Signaturefd LLC	882	$73K	0.0%	-38.8%	0.000%
7/29/2024	Crossmark Global Holdings Inc.	11,045	$0.91M	0.0%	N/A	0.006%
7/29/2024	Principal Financial Group Inc.	649,460	$53.47M	0.0%	+1,858.6%	0.342%
7/29/2024	Innealta Capital LLC	299	$25K	0.0%	N/A	0.000%
7/29/2024	Panagora Asset Management Inc.	14,055	$1.16M	0.0%	-21.3%	0.007%
7/29/2024	Whittier Trust Co.	377	$31K	0.0%	-81.8%	0.000%
7/26/2024	State of Michigan Retirement System	45,700	$3.76M	0.0%	N/A	0.024%
7/26/2024	AlphaCentric Advisors LLC	16,500	$1.36M	1.0%	+6.5%	0.009%

Data available starting January 2016

BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria (PKU), an inherited metabolic disease. The company's commercial products also comprise Palynziq, a PEGylated recombinant phenylalanine ammonia lyase enzyme, which is delivered through subcutaneous injection to reduce blood Phe concentrations; Brineura, a recombinant human tripeptidyl peptidase 1 for the treatment of patients with ceroid lipofuscinosis type 2, a form of Batten disease; Voxzogo, a once daily injection analog of c-type natriuretic peptide for the treatment of achondroplasia; and Aldurazyme, a purified protein designed to be identical to a naturally occurring form of the human enzyme alpha-L-iduronidase. In addition, it develops Roctavian, an adeno associated virus vector, for the treatment of patients with severe hemophilia A. The company serves specialty pharmacies, hospitals, and non-U.S. government agencies, as well as distributors and pharmaceutical wholesalers in the United States, Europe, Latin America, and internationally. BioMarin Pharmaceutical Inc. has license and collaboration agreements with Sarepta Therapeutics, Ares Trading S.A., Catalyst Pharmaceutical Partners, Inc. The company was incorporated in 1996 and is headquartered in San Rafael, California.

Today's Range

Now: $71.41

$70.42

$72.02

50 Day Range

MA: $86.11

$69.86

$93.84

52 Week Range

Now: $71.41

$68.83

$99.56

Volume

2,933,520 shs

Average Volume

1,908,398 shs

Market Capitalization

$13.56 billion

P/E Ratio

66.74

Dividend Yield

N/A

Beta

0.32

Who are the company insiders with the largest holdings of BioMarin Pharmaceutical?: BioMarin Pharmaceutical's top insider shareholders include:
Jean Jacques Bienaime (Director)
Jean Jacques Bienaime (CEO)
Henry J Fuchs (Insider)
Jeffrey Robert Ajer (EVP)
Brian Mueller (CFO)
George Eric Davis (EVP)
V Bryan Lawlis (Director)
Erin Burkhart (CAO)
Mark J Alles (Director)
Learn More about top insider investors at BioMarin Pharmaceutical.
Who are the major institutional investors of BioMarin Pharmaceutical?: BioMarin Pharmaceutical's top institutional investors include:
Primecap Management Co. CA — 9.90%
Avoro Capital Advisors LLC — 2.40%
Dimensional Fund Advisors LP — 0.54%
DNB Asset Management AS — 0.54%
Fort Washington Investment Advisors Inc. OH — 0.52%
Principal Financial Group Inc. — 0.34%
Learn More about top institutional investors of BioMarin Pharmaceutical stock.
Which major investors are selling BioMarin Pharmaceutical stock?: During the previous quarter, BMRN stock was sold by these institutional investors:
AXA S.A.
Renaissance Technologies LLC
National Bank of Canada FI
Fort Washington Investment Advisors Inc. OH
D. E. Shaw & Co. Inc.
Hsbc Holdings PLC
Canada Pension Plan Investment Board
APG Asset Management N.V.
During the previous year, company insiders that have sold BioMarin Pharmaceutical company stock include:
Jean Jacques Bienaime (Director)
Jean Jacques Bienaime (CEO)
Henry J Fuchs (Insider)
Jeffrey Robert Ajer (EVP)
Brian Mueller (CFO)
George Eric Davis (EVP)
Learn More investors selling BioMarin Pharmaceutical stock.
Which major investors are buying BioMarin Pharmaceutical stock?: During the last quarter, BMRN stock was bought by institutional investors including:
Principal Financial Group Inc.
Assenagon Asset Management S.A.
Rhumbline Advisers
Dimensional Fund Advisors LP
Retirement Systems of Alabama
Avoro Capital Advisors LLC
DNB Asset Management AS
Employees Retirement System of Texas